Format

Send to

Choose Destination
J Inherit Metab Dis. 2006 Aug;29(4):593. Epub 2006 Jun 19.

Copper concentration of liver tissue under long-term copper-histidine therapy in a patient with Menkes disease.

Author information

1
Department of General Paediatrics, University Hospital Graz, Graz, Austria.

Abstract

Copper-histidine is the treatment of choice in Menkes disease but bears the potential risk of copper overload and induced liver cirrhosis. We report normal copper concentrations of liver tissue over an 8-year treatment period with copper-histidine.

PMID:
16786254
DOI:
10.1007/s10545-006-0312-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center